The presence of anti-CD4 autoantibodies in treatment-naive patients with advanced HIV was associated with a decreased rate of CD4 reconstitution following ART initiation.
MedPage Today on MSN2d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
The advent of antiretroviral therapy (ART), once-daily single tablet regimens (STRs) with three medications combined into one pill, and many subsequent improvements in STRs combining efficacy and ...
11hon MSN
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...
The global HIV drugs industry was valued at USD 28.6 billion in 2023 and is projected to grow at a CAGR of 4.7% from 2024 to ...
Although HIV can be treated and managed with antiretroviral therapy (ART), the virus cannot yet ... "This exciting improvement in NK cell therapy gives me hope not just for its applications ...
Long-Term Outcomes Reinforce the High Efficacy of Biktarvy ® in People with HIV and HBV Coinfection – – Investigational Long-Acting, Twice-Yearly Treatment Regimen of Len ...
In HIV-1-infected patients with extensive drug resistance, the optimization of background antiretroviral therapy is essential when changing drugs after treatment failure. The genotypic sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback